Price reductions needed to make groundbreaking Alzheimer’s drugs available – study
Irish study of 174 countries finds that the real-world impact of innovative treatments will depend on whether they…
Less than 20% of patients in Japan interested in new Alzheimer’s drugs received one
Less than 20% of people who showed interest in taking new medications for Alzheimer’s disease went on to…